Dr. Abel is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2 Tampa General Cir
Tampa, FL 33606Phone+1 813-250-2287Fax+1 813-259-0608
Education & Training
- Emory University School of MedicineResidency, Physical Medicine and Rehabilitation, 1988 - 1991
- Medical College of GeorgiaInternship, Internal Medicine, 1987 - 1988
- Medical College of Georgia at Augusta UniversityClass of 1987
Certifications & Licensure
- FL State Medical License 1992 - 2026
- GA State Medical License 1989 - 1997
- American Board of Physical Medicine and Rehabilitation Physical Medicine & Rehabilitation
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2011-2013
Clinical Trials
- Assessment of ShuntCheck Performance Characteristics in Asymptomatic Patients With Normal Pressure Hydrocephalus Start of enrollment: 2019 Jun 11
Publications & Presentations
PubMed
- 123 citationsPeripheral Nerve Injury: Stem Cell Therapy and Peripheral Nerve Transfer.Robert Sullivan, Travis Dailey, Kelsey Duncan, Naomi Abel, Cesario V. Borlongan
International Journal of Molecular Sciences. 2016-12-14 - 101 citationsAnalysis of lumbar plexopathies and nerve injury after lateral retroperitoneal transpsoas approach: diagnostic standardization.Amir Ahmadian, Armen R. Deukmedjian, Naomi Abel, Elias Dakwar, Juan S. Uribe
Journal of Neurosurgery. Spine. 2013-03-01 - 33 citationsFemoral nerve and lumbar plexus injury after minimally invasive lateral retroperitoneal transpsoas approach: electrodiagnostic prognostic indicators and a roadmap to r...Naomi Abel, Jacob Januszewski, Andrew C. Vivas, Juan S. Uribe
Neurosurgical Review. 2018-04-01
Press Mentions
- Innovative Drug Aims to Improve Hydrocephalus Treatment and Delay Onset of Alzheimer’s and Parkinson’s DiseaseJune 25th, 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: